Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
10,581,307
-
Share change
-
+6,597,561
-
Total reported value
-
$36,188,750
-
Put/Call ratio
-
567%
-
Price per share
-
$3.50
-
Number of holders
-
56
-
Value change
-
+$22,758,975
-
Number of buys
-
35
-
Number of sells
-
15
Institutional Holders of ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) as of Q3 2018
As of 30 Sep 2018,
ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,581,307 shares.
The largest 10 holders included
FIRST MANHATTAN CO, Vanguard Group Inc, DekaBank Deutsche Girozentrale, BlackRock Inc., 683 Capital Management, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, BARD ASSOCIATES INC, and PERCEPTIVE ADVISORS LLC.
This page lists
56
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.